Skip to main content

Table 3 Results of modified FOLFOX-6 chemotherapy

From: Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker

Response No. of Pts (%)
Complete response 0 (0.0)
Partial response 32 (43.8)
Stable disease 21 (28.8)
Progressive disease 20 (27.4)